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N-acetylglucosamine-phosphate mutase (AGM1) is an essential enzyme in the
synthesis of UDP-N-acetylglucosamine (UDP-GlcNAc) in eukaryotes and
belongs to the  -d-phosphohexomutase superfamily. AGM1 from Candida
albicans (CaAGM1) was puriﬁed and crystallized by the sitting-drop vapour-
diffusion method. The crystals obtained belong to the primitive monoclinic
space group P21, with unit-cell parameters a = 60.2, b = 130.2, c = 78.0 A ˚ ,
  = 106.7 . The crystals diffract X-rays to beyond 1.8 A ˚ resolution using
synchrotron radiation.
1. Introduction
UDP-N-acetylglucosamine (UDP-GlcNAc) is a UDP sugar and is
synthesized from fructose-6-phosphate supplied by the glycolytic
pathway (Watzele & Tanner, 1989; Mio et al., 1999; Hofmann et al.,
1994; Mio et al., 1998). UDP-GlcNAc is used as a precusor in the
synthesis of cell-wall chitin and glycoproteins. Although UDP-
GlcNAc is also utilized in mammalian cells, fungi require a larger
amount of UDP-GlcNAc owing to the synthesis of the cell wall.
N-Acetylglucosamine-phosphate mutase (AGM1; EC 5.4.2.3) is an
essential enzyme in the synthesis of UDP-GlcNAc. AGM1 catalyzes
the intramolecular transfer of a phosphoryl group. This synthetic step
consists of the interconversion of N-acetylglucosamine-6-phosphate
(GlcNAc-6-P) and N-acetylglucosamine-1-phosphate (GlcNAc-1-P).
The process of UDP-GlcNAc biosynthesis differs in prokaryotes and
eukaryotes and AGM1 has only been identiﬁed in eukaryotes (Mio et
al., 2000). It is well known that AGM1 requires Mg
2+ ions to exhibit
maximum activity; complete inhibition has also been achieved with
Zn
2+ ions (Cheng & Carlson, 1979; Fernandez-Sorensen & Carlson,
1971). AGM1 is a member of the  -d-phosphohexomutase super-
family, as it catalyzes a reversible intramolecular phosphoryl transfer
on its sugar substrate (Shackelford et al., 2004; Whitehouse et al.,
1998). Other superfamily members exist as various oligomeric states
(monomers, dimers and trimers) in solution (Jolly et al., 1999; Maino
& Young, 1974). Phosphomannomutase/phosphoglucomutase from
Pseudomonas aeruginosa (PaPMM/PGM; PDB code 1k2y), which
catalyzes the reversible conversion of mannose-6-phosphate to
mannose-1-phosphate and glucose-6-phosphate to glucose-1-phos-
phate, shares 20.7% sequence identity with AGM1 from Candida
albicans (CaAGM1) as calculated by theprogram FASTA (Lipman &
Pearson, 1985; Pearson & Lipman, 1988) and exists as a monomer in
solution (Regni et al., 2002, 2004). Several structures of enzymes in
this superfamily have been reported to date. They are similar to each
other, being composed of four domains arranged in a ‘heart shape’
(Liu, 1997; Regni et al., 2002, 2004). However, for AGM1 only the
atomic coordinates of the C-terminal domain from Mus musculus
(112 amino-acid residues of 542 amino-acid residues) has been
deposited (PDB code 1wjw) and overall structures have not been
determined. Multiple sequence alignment in the superfamily shows
that AGM1 has signiﬁcant sequence similarity to other members with
regard to the presumed active-site loops, but that AGM1 has a
different relative location of several loops; these loops were not
identiﬁed as affecting the activity by previous mutation analysis
(Shackelford et al., 2004; Mio et al., 2000). Also, little is known about
the substrate speciﬁcity. Determination of the three-dimensional
structure of this enzyme is thus necessary in order to gain a better
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additional important differences betweeen the enzymes included in
this superfamily.
Here, we describe the puriﬁcation, crystallization and preliminary
X-ray data for CaAGM1. C. albicans is a disease-causing fungus that
leads to a life-threatening systemic infection (referred to as ‘candi-
dasis’) in immunocompromized hosts (Rogers & Balish, 1980). It is
impossible for fungi to live without biosynthesis of the cell wall and
the chitin of the cell wall is synthesized from UDP-GlcNAc. A
speciﬁc inhibitor of AGM1 from pathogenic fungi could therefore be
a new candidate antifungal reagent that would inhibit cell-wall
synthesis.
2. Purification
CaAGM1 is composed of 544 amino-acid residues and its molecular
weight is about 60 kDa. For the crystallization experiments, the ORF
of CaAGM1 was cloned between the BamHI and EcoRI sites of
pGEX-2T to express CaAGM1 as a glutathione S-transferase (GST)
fusion. CaAGM1 was overproduced and sonicated by previously
described methods (Mio et al., 2000), except that after the addition of
isopropyl 1-thio-galactopyranoside the cells were grown for an
additional 22 h at 295 K. The soluble fraction was applied onto a
Glutathione Sepharose 4 FastFlow column (Amersham Biosciences,
Piscataway, NJ, USA) and was washed with PBS at 277 K. The
puriﬁed protein was eluted with a GST elution buffer (20 mM Tris–
HCl, 0.15 M NaCl, 10 mM glutathione pH 8.5). The GST was then
removed by a 16 h treatment with thrombin at 277 K. Finally, this
solution was applied onto a DEAE-Toyopearl 650 column (Tosoh,
Tokyo, Japan) and eluted using a gradient of 0–0.5 M NaCl contained
in elution buffer [20 mM Tris–HCl, 1 mM EDTA, 5%(v/v) glycerol
pH 7.5] at 277 K. The purity of the fraction used for crystallization
was tested by SDS–PAGE. Gel-ﬁltration chromatography analysis
(data not shown) suggested that the puriﬁed protein exists as a
monomer in solution. The ﬁnal yield of CaAGM1 per litre of culture
is approximately 2.5 mg. It was desalted and concentrated to a
volume of 10 mg ml
 1.
3. Crystallization
Crystallization attempts were carried out using Crystal Screens 1 and
2, Crystal Screen Cryo and PEG/Ion Screen (Hampton Research,
Aliso Viejo, CA, USA). All attempts at crystallization were
performed using the sitting-drop vapour-diffusion method at 293 K.
Mixtures of 1.25 ml protein solution (10 mg ml
 1 in 50 mM Tris–HCl
pH 7.6 and 1 mM dithiothreitol) and an equal volume of the reservoir
solution were equilibrated against 100 ml reservoir solution. Crystals
were obtained using reservoir solution containing 200 mM
NH4H2PO4 and 14–20%(w/v) polyethylene glycol 3350 within a week
with approximate dimensions of 0.5   0.2   0.03 mm (Fig. 1).
4. X-ray data collection
The crystals were soaked brieﬂy in a cryoprotectant solution
prepared by the addition of 15%(v/v) glycerol to the reservoir solu-
tion and the crystals were mounted in a loop and ﬂash-cooled in an N2
gas stream at 95 K. X-ray diffraction studies were performed at
SPring-8 (BL44B2) and the Photon Factory (BL5). The diffraction
data used for the reﬁnement were collected at BL44B2 with a MAR
CCD detector using an oscillation angle of 0.5 , 15 s exposure per
frame and a wavelength of 1.000 A ˚ . The crystal-to-detector distance
was set at 115 mm. Diffraction was observed to a resolution
exceeding 1.8 A ˚ . The data set from a single crystal was processed and
scaled using the programs DENZO and SCALEPACK from the
HKL2000 package (Otwinowski & Minor, 1997).
The crystals were found to belong to the primitive monoclinic
system and systematic absences of reﬂections (k =2 n +1a t0 k0)
indicated the space group of the data set to be P21. The statistics for
the intensity data are shown in Table 1. Assuming the presence of two
CaAGM1 molecules per asymmetric unit, the calculated Matthews
coefﬁcient VM was 2.42 A ˚ 3 Da
 1 (Matthews, 1968), which corre-
sponds to a solvent content of 49.2%. Phasing by the multiple
isomorphous replacement method and the structure reﬁnement were
successful and the structure will be published soon.
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Figure 1
Crystal of CaAGM1.
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